Aurelien Traversier

Lyon, 69007, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Chemical modification of sialylated oligosaccharides to functionalize nanostructured lipid carriers: exploring two different strategies.

Chemical modification of sialylated oligosaccharides to functionalize nanostructured lipid carriers: exploring two different strategies.

Journal: Organic & biomolecular chemistry
Published: May 08, 2025

Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor.

Metavac-RSV mucosal bivalent vaccine candidate protects cotton rats against pneumoviruses and is produced using serum-free cell culture in bioreactor.

Journal: NPJ vaccines
Published: March 13, 2025

Host-targeted repurposed diltiazem enhances the antiviral activity of direct acting antivirals against Influenza A virus and SARS-CoV-2.

Host-targeted repurposed diltiazem enhances the antiviral activity of direct acting antivirals against Influenza A virus and SARS-CoV-2.

Journal: Antiviral research
Published: November 30, 2024

Impaired mucosal IgA response in patients with severe COVID-19.

Impaired mucosal IgA response in patients with severe COVID-19.

Journal: Emerging microbes & infections
Published: October 03, 2024

A combinatorial and computational Tandem approach towards a universal therapeutics against ACE2-mediated coronavirus infections.

A combinatorial and computational Tandem approach towards a universal therapeutics against ACE2-mediated coronavirus infections.

Journal: iScience
Published: September 04, 2024

Author Correction: Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.

Author Correction: Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.

Journal: NPJ vaccines
Published: July 09, 2024

Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.

Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice.

Journal: NPJ vaccines
Published: October 24, 2023

Biotechnological production of sialylated solid lipid microparticles as inhibitors of influenza A virus infection.

Biotechnological production of sialylated solid lipid microparticles as inhibitors of influenza A virus infection.

Journal: Glycobiology
Published: July 01, 2022

Interactions Between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium.

Interactions Between Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Major Respiratory Viruses in Human Nasal Epithelium.

Journal: The Journal of infectious diseases
Published: June 02, 2022

Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac®.

Avian Cell Line DuckCelt®-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac®.

Journal: Vaccines
Published: September 13, 2021

Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model.

Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model.

Journal: Microorganisms
Published: November 03, 2020

Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples.

Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples.

Journal: The Journal of infectious diseases
Published: May 23, 2020
Showing 1-12 of 28

Last Updated: 09/26/2026